| 1 |
Arabzadeh A, Mortezazadeh T, Aryafar T, Gharepapagh E, Majdaeen M, Farhood B. Therapeutic potentials of resveratrol in combination with radiotherapy and chemotherapy during glioblastoma treatment: a mechanistic review. Cancer Cell Int 2021;21:391. [PMID: 34289841 DOI: 10.1186/s12935-021-02099-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 2 |
Seifert C, Balz E, Herzog S, Korolev A, Gaßmann S, Paland H, Fink MA, Grube M, Marx S, Jedlitschky G, Tzvetkov MV, Rauch BH, Schroeder HWS, Bien-Möller S. PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells. Int J Mol Sci 2021;22:11126. [PMID: 34681783 DOI: 10.3390/ijms222011126] [Reference Citation Analysis]
|
| 3 |
Pucko EB, Ostrowski RP. Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms. Pharmaceutics 2022;14:331. [DOI: 10.3390/pharmaceutics14020331] [Reference Citation Analysis]
|
| 4 |
Fulghieri P, Stivala LA, Sottile V. Modulating cell differentiation in cancer models. Biochem Soc Trans 2021;49:1803-16. [PMID: 34436513 DOI: 10.1042/BST20210230] [Reference Citation Analysis]
|
| 5 |
Warrier NM, Agarwal P, Kumar P. Integrative Analysis to Identify Genes Associated with Stemness and Immune Infiltration in Glioblastoma. Cells 2021;10:2765. [PMID: 34685742 DOI: 10.3390/cells10102765] [Reference Citation Analysis]
|
| 6 |
Putthisen S, Silsirivanit A, Panawan O, Niibori-Nambu A, Nishiyama-Ikeda Y, Ma-In P, Luang S, Ohta K, Muisuk K, Wongkham S, Araki N. Targeting alpha2,3-sialylated glycan in glioma stem-like cells by Maackia amurensis lectin-II: A promising strategy for glioma treatment. Exp Cell Res 2022;410:112949. [PMID: 34843714 DOI: 10.1016/j.yexcr.2021.112949] [Reference Citation Analysis]
|
| 7 |
Han M, Kim JM, Cheong JH, Ryu JI, Won YD, Nam GH, Kim CH. Efficacy of Cytokine-Induced Killer Cell Immunotherapy for Patients With Pathologically Pure Glioblastoma. Front Oncol 2022;12:851628. [DOI: 10.3389/fonc.2022.851628] [Reference Citation Analysis]
|
| 8 |
Dekker LJM, Verheul C, Wensveen N, Leenders W, Lamfers MLM, Leenstra S, Luider TM. Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures. ACS Omega. [DOI: 10.1021/acsomega.1c06121] [Reference Citation Analysis]
|
| 9 |
Zhang M, Chen H, Liang B, Wang X, Gu N, Xue F, Yue Q, Zhang Q, Hong J. Prognostic Value of mRNAsi/Corrected mRNAsi Calculated by the One-Class Logistic Regression Machine-Learning Algorithm in Glioblastoma Within Multiple Datasets. Front Mol Biosci 2021;8:777921. [PMID: 34938774 DOI: 10.3389/fmolb.2021.777921] [Reference Citation Analysis]
|
| 10 |
Sevastre AS, Costachi A, Tataranu LG, Brandusa C, Artene SA, Stovicek O, Alexandru O, Danoiu S, Sfredel V, Dricu A. Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review). Exp Ther Med 2021;22:1408. [PMID: 34676001 DOI: 10.3892/etm.2021.10844] [Reference Citation Analysis]
|
| 11 |
Sun W, Yan J, Ma H, Wu J, Zhang Y. Autophagy-Dependent Ferroptosis-Related Signature is Closely Associated with the Prognosis and Tumor Immune Escape of Patients with Glioma. Int J Gen Med 2022;15:253-70. [PMID: 35023963 DOI: 10.2147/IJGM.S343046] [Reference Citation Analysis]
|
